Bariatric surgery for type 2 diabetes: weighing the impact for obese patients - PubMed (original) (raw)

Review

Bariatric surgery for type 2 diabetes: weighing the impact for obese patients

Sangeeta R Kashyap et al. Cleve Clin J Med. 2010 Jul.

Abstract

Obesity is a potent risk factor for the development and progression of type 2 diabetes, and weight loss is a key component of diabetes management. Bariatric surgery results in significant weight loss and remission of diabetes in most patients. After surgery, glycemic control is restored by a combination of enforced caloric restriction, enhanced insulin sensitivity, and increased insulin secretion.

PubMed Disclaimer

Figures

Figure 1

Figure 1

How gut hormones may contribute to regression of diabetes after Roux-en-Y surgery

Comment in

References

    1. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004;88:787–835. - PubMed
    1. Kashyap SR, Defronzo RA. The insulin resistance syndrome: physiological considerations. Diab Vasc Dis Res. 2007;4:13–19. - PubMed
    1. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–79. - PubMed
    1. Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology. 2003;144:5159–5165. - PubMed
    1. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes. 2002;51:2005–2011. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources